The Department of Veterans Affairs (VA) is issuing a combined synopsis/solicitation notice for the procurement of reagents and consumables, under solicitation number 36C26225Q0514. The response deadline for bids is set for February 27, 2025, at 9:00 AM Pacific Time. This opportunity is associated with the VA Greater Los Angeles Healthcare System, located at 11301 Wilshire Blvd, Los Angeles, CA 90073. The contracting office is situated in Long Beach, CA, under Network Contracting Office 22. Relevant attachments, including the Request for Quotation (RFQ) and the Statement of Work (SOW), provide detailed specifications and requirements for bidders. This solicitation does not involve Recovery Act funds and utilizes Product Service Code 6550 as well as NAICS Code 325413. Interested parties should contact Carlos Magana via email for inquiries related to this procurement. The announcement reflects the VA's ongoing efforts to source essential materials to support healthcare services for veterans.
The document outlines a Request for Proposal (RFP) focusing on various healthcare products from Fisher Healthcare, detailing specific equipment and assays essential for certain medical procedures. It categorizes items by their Clinical Line Item Number (CLIN) and highlights the corresponding salient characteristics and manufacturer part numbers. The file also emphasizes the need for equivalent products that match specified characteristics, allowing for flexibility in sourcing the required medical supplies. Key products include various Oncomine assays, Ion Chips, and Qubit assay kits, all critical in genomic and molecular analysis. This document serves as a structured key reference point for vendors to submit competitive bids aligned with federal procurement protocols, ensuring compliance with quality and performance metrics essential to healthcare service delivery.
The Statement of Work (SOW) outlines the responsibilities of a selected contractor to provide reagents and supplies for next-generation sequencing testing at the VA Greater Los Angeles Healthcare System (VAGLAHS). Located at 11301 Wilshire Blvd, CA, VAGLAHS is a prestigious teaching hospital known for its molecular oncology testing capabilities. The scope includes obtaining specific reagents compatible with Ion Torrent systems for analyzing myeloid and solid tumor DNA and RNA, detailing a comprehensive list of required gene identifiers and corresponding assay products.
Contractor operations will align with the facility's standard hours, but flexibility is expected to accommodate 24/7 service needs. Throughout, strict adherence to security protocols is emphasized; this includes maintaining data integrity and personnel background checks according to federal regulations. The document mandates that any contractor work must ensure compliance with VA policies to protect sensitive information and uphold a high standard of operational security. By detailing these requirements, the SOW establishes a framework for enhancing healthcare services through advanced genomic testing capabilities within the VA system.
The U.S. Department of Veterans Affairs (VA) is issuing a Request for Quotation (RFQ) under solicitation number 36C26225Q0514 to procure reagents and consumables on a need basis for the VA Greater Los Angeles Healthcare System. The RFQ follows FAR Part 13 Simplified Acquisition Procedures and aims to award a single Firm-Fixed Price contract through competitive bidding. Interested businesses must act under NAICS Code 325413, adhering to specified brand name or equal characteristics outlined in Attachments A (Pricing) and B (Statement of Work). Proposals are due by February 27, 2025, at 9:00 AM PST, and must demonstrate compliance with technical specifications; late submissions will not be accepted. The government will evaluate offers based on technical capability, price, and adherence to salient characteristics. Proposals should be submitted electronically, and inquiries must be directed to the designated contact by the specified deadline. The contract is expected to commence from February 27, 2025, to February 26, 2026, with additional terms related to delivery and performance outlined in the document. Compliance with various clauses and supplier conditions, including the prohibition of gray market items, is also stipulated for this procurement process.